IMBA INST FUR MOLEKULARE BIOTECHNOLOGIE GMBH has a total of 19 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2004. It filed its patents most often in Canada, Australia and Republic of Korea. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UNIVERSITATSKLINIKUM HAMBURG E, KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN and CELGENE ALPINE INVEST COMPANY II LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | Australia | 5 | |
#3 | Republic of Korea | 3 | |
#4 | China | 2 | |
#5 | Japan | 2 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Sugars | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Penninger Josef | 7 |
#2 | Knoblich Jurgen | 5 |
#3 | Herzog Veronika A | 3 |
#4 | Ameres Stefan L | 3 |
#5 | Reichholf Brian | 3 |
#6 | Zuber Johannes | 3 |
#7 | Muhar Matthias | 3 |
#8 | Bian Shan | 2 |
#9 | Wimmer Reiner | 2 |
#10 | Kerjaschki Dontscho | 2 |
Publication | Filing date | Title |
---|---|---|
CN111065732A | Tumor organoid model | |
CA3010755A1 | Supported in vitro developed tissue culture and culturing methods |